Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  HCP, Inc.    HCP

Delayed Quote. Delayed  - 07/22 10:01:04 pm
38.9 USD   +0.91%
07/13 LAWSUIT FOR INV : HCP) Against Certain Directors over Alleged Miscon..
07/13 ROBBINS ARROYO : HCP, Inc. (HCP) Misled Shareholders According to a..
07/11DJHCP : Chief Leaves Company, Chairman Adds Role on Interim Basis
News SummaryMost relevantAll newsSector news 

HCP, Inc. : HCP 1Q Net More Than Doubles As Revenue Surges; Lifts Fiscal Year View

share with twitter share with LinkedIn share with facebook
share via e-mail
05/01/2012 | 02:59pm CEST

HCP Inc.'s (HCP) first-quarter net income more than doubled as revenue soared and the health-care real-estate investment trust recorded better-than-expected growth in a key performance metric.

The REIT--whose investments include senior housing, medical offices and skilled-nursing properties--has had its revenue steadily grow with help from several acquisitions.

Looking ahead, HCP raised its full-year outlook for funds for operations, a key measure of performance for REITs, by a penny. It nows expects FFO of $2.71 to $2.77 for the year.

For the first quarter, the company reported a profit of $193.4 million, up sharply from a year-earlier profit of $70.1 million. On a per-share basis, which reflects the payment of preferred dividends, earnings jumped to 43 cents from 17 cents a year earlier, matching analyst expectations.

Overall revenue climbed 39% to $459 million. Analysts polled by Thomson Reuters expected $463 million.

Adjusted fund from operations rose to 67 cents from 56 cents, topping the 66 cents analysts expected.

Shares closed Monday at $41.45 and were inactive premarket. The stock is up 4.6% over the past 12 months.

-By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on HCP, INC.
07/13 LAWSUIT FOR INVESTORS IN SHARES OF H : HCP) Against Certain Directors over Alleg..
07/13 ROBBINS ARROYO LLP : HCP, Inc. (HCP) Misled Shareholders According to a Recently..
07/11DJHCP : Chief Leaves Company, Chairman Adds Role on Interim Basis
07/11 HCP : Announces CEO Transition
07/11 HCP, INC. : DEADLINE TODAY: Khang & Khang LLP Announces the Filing of a Securiti..
07/08 HCP, INC. : 3-DAY DEADLINE ALERT: Lundin Law PC Announces Securities Class Actio..
07/08 3-DAY DEADLINE ALERT : Lundin Law PC Announces Securities Class Action Lawsuit A..
07/08 HCP, INC. : FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Investor..
07/08 UPCOMING DEADLINE : Levi & Korsinsky, LLP Reminds Shareholders of HCP, Inc. of C..
07/08 INVESTOR NOTICE : Goldberg Law PC Announces Securities Class Action Lawsuit Agai..
More news
Sector news : Healthcare REITs
07/21DJCROWN CASTLE : Raises Guidance, Despite Second-Quarter Miss
07/05DJVentas Signs $1.5 Billion Life Sciences-Focused Deal
07/05DJVENTAS : Signs $1.5 Billion Life Sciences-Focused Deal
07/01 Deutsche Telekom looks to sell off German mobile masts - sources
06/02 WELLTOWER : Mainstreet Health plans senior housing deals after Canadian listing
More sector news : Healthcare REITs
News from SeekingAlpha
07/22 6 MONTH PORTFOLIO UPDATE : Good News, Double-Digit Increase In Both Income And V..
07/21 SOTP Valuation Indicates The HCP Stock Has Already Priced In The Benefits Of ..
07/19 Both The DGI10 And TR7 Portfolios Continue To Outperform The Market
07/18 THE REIT INDUSTRY AND ITS RISING STA : Physicians Realty Trust
07/18 MY 80 STOCK PORTFOLIO REVIEW : Revealing All Account Types - Taxable, Roth And O..
Financials ($)
Sales 2016 2 544 M
EBIT 2016 1 267 M
Net income 2016 686 M
Debt 2016 9 965 M
Yield 2016 5,85%
P/E ratio 2016 27,14
P/E ratio 2017 24,52
EV / Sales 2016 11,1x
EV / Sales 2017 10,7x
Capitalization 18 170 M
More Financials
Chart HCP, INC.
Duration : Period :
HCP, Inc. Technical Analysis Chart | HCP | US40414L1098 | 4-Traders
Full-screen chart
Technical analysis trends HCP, INC.
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 17
Average target price 32,4 $
Spread / Average Target -17%
Consensus details
EPS Revisions
More Estimates Revisions
Michael Dale McKee Executive Chairman, President & CEO
Thomas M. Herzog Chief Financial Officer & Executive Vice President
Keith Bereskin SVP-Information Technology & Building Operations
Joseph P. Sullivan Independent Director
Peter L. Rhein Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HCP, INC.1.73%18 170
WELLTOWER INC15.76%28 113
VENTAS, INC.30.92%25 862
More Results